#JPM26: Drugmakers want US reforms, not to slow down Chinanews2026-01-14T16:10:57+00:00January 14th, 2026|Endpoints News|
#JPM26: Day 3 at the JP Morgan Healthcare Conferencenews2026-01-14T12:00:12+00:00January 14th, 2026|Endpoints News|
#JPM26: Q&A with Bristol Myers Squibb CEO Chris Boerner on 2026 outlooknews2026-01-14T11:45:48+00:00January 14th, 2026|Endpoints News|
FDA delays decision on expanding label for Travere’s kidney disorder drugnews2026-01-13T21:19:40+00:00January 13th, 2026|Endpoints News|
FDA asks Lilly, Novo to remove suicide warnings from GLP-1 labelsnews2026-01-13T19:00:55+00:00January 13th, 2026|Endpoints News|
HHS ousts vaccine injury panel members as reshaping takes holdnews2026-01-13T18:32:24+00:00January 13th, 2026|Endpoints News|
Trump administration appears to have ended its US trade probe into pharmanews2026-01-13T18:02:35+00:00January 13th, 2026|Endpoints News|
AbbVie reaches MFN deal with the White House, pledges billions to US manufacturingnews2026-01-13T14:53:42+00:00January 13th, 2026|Endpoints News|
#JPM26: Day 2 at the JP Morgan Healthcare Conferencenews2026-01-13T12:00:15+00:00January 13th, 2026|Endpoints News|
Sentynl gets the first US approval for rare copper absorption diseasenews2026-01-13T10:49:44+00:00January 13th, 2026|Endpoints News|
